The integration enables streaming of the patient’s NOL-Nociception Level Index® data to EHRs, supporting personalized analgesia in surgery and critical care.
Objective pain-monitoring data obtained via Medasense’s PMD-200™ patient monitor and its NOL-Nociception Level Index® can now be documented and accessed alongside other patient data within hospital electronic health records (EHRs) and clinical information systems, giving clinicians a more complete view of patient status and supporting data-driven analgesia management. Medasense Biometrics announced today that the new capability is enabled through the integration of its PMD-200™ monitor with Philips Capsule Medical Device Information Platform (MDIP).
Key Benefits of the Integration
- Automated EMR documentation: The NOL Index and trend data are streamed directly to the patient’s electronic health record, eliminating manual data entry and reducing transcription errors.
- Vendor-neutral interoperability: Through Philips Capsule MDIP, the PMD-200 data can be routed to any major EHR system — including Epic, Oracle/Cerner, MEDITECH, and others — using established, industry standard communication protocols.
- Clinical surveillance and analytics: NOL Index data becomes available for integration into hospital clinical surveillance and analytics platforms, enabling proactive patient safety workflows.
- Real-world evidence support: Continuous, timestamped NOL data captured in the EHR creates a foundation for retrospective research, quality improvement studies, and real-world evidence generation to further validate nociception-guided analgesia protocols.
- Streamlined clinical workflow: Clinicians can access the NOL Index within the same interface they use for all other patient monitoring data, reducing cognitive burden and supporting a unified view of the patient’s physiological status.
